A manufacturer's representative arrives to present a piece of equipment. Somewhere in that meeting, usually after the clinical demonstration and before the paperwork, financing enters the conversation. A monthly payment appears. It is affordable, the term is manageable, and the equipment is already sitting in the room being impressive.
That moment is the single most common way clinic equipment gets financed in North America, and it is also the moment where the least comparison shopping happens. Not because operators are careless, but because the structure of the conversation makes the financing feel like a detail attached to the equipment rather than a separate transaction with its own price.
It is a separate transaction. Understanding how vendor finance programs are funded explains why.
Where vendor financing money actually comes from
Vendor financing is not one thing. It arrives through several arrangements that look identical from the operator's chair.
Some manufacturers operate a captive finance company, a wholly owned subsidiary whose purpose is to finance the parent company's equipment. Others partner with an independent lessor or bank that underwrites the paper under the manufacturer's brand. In a third arrangement, the manufacturer refers to a finance company without owning any part of the transaction. From the buyer's side these often present the same way, as a payment offered by the person selling the equipment.
The distinction matters because of how a captive program can be funded. A bank needs each individual loan to earn its own return. A captive finance company does not, because the manufacturer can absorb part of the financing cost in order to sell more equipment. In vehicle finance, where the practice is most visible, this is called subvention, and it produces the below-market and zero-percent offers that appear on new models. The money is not free. It comes out of the manufacturer's sales and incentive budget, which means it is funded by the margin on the equipment.
Once that is clear, the shape of the equipment finance conversation changes. There are two prices in the room. The price of the equipment, and the price of the money. They are drawn from the same pool.
The trade-off, stated by a neutral source
The clearest confirmation of this comes from a party with nothing to sell. The Business Development Bank of Canada, the federal Crown corporation lender, describes manufacturer finance divisions as offering discounts specifically to stimulate sales, and notes that the resulting deals are often genuinely difficult to beat on new equipment, including offers where the buyer is given a choice between taking a lower interest rate or taking cash back.
That choice is the whole point. When a program presents a low rate and a cash discount as alternatives, it is stating plainly that both are being paid for from the same budget. The buyer selects which form the incentive takes. It is not a hidden practice and it is not improper. It is simply the economics of the arrangement made visible for a moment.
The problem is that outside those explicit either-or promotions, the trade-off is usually not presented as a choice. A quoted equipment price and a quoted financing rate arrive together as a single package, and nothing in the conversation signals that one may have been adjusted to support the other. An operator negotiating hard on the equipment price may find the financing quietly less competitive. An operator delighted by a promotional rate may not think to ask what the equipment would have cost paid outright.
Two further details are worth knowing. Some vendors price cash purchases differently from financed purchases, which is the same trade-off appearing in a more direct form. And some reduce warranty coverage on financed equipment, which is a cost that does not appear anywhere in the payment.
Why the monthly payment is the wrong number to compare
Financing presented at the point of sale is almost always presented as a monthly payment. That framing is genuinely useful for an operator thinking about cash flow, and it is also the number that reveals the least.
A payment can be reduced by extending the term, by increasing a residual or balloon at the end, or by shifting cost into fees. None of those reduce what the equipment costs. Two quotes with similar monthly payments can differ materially in total cost across the term, and the difference is invisible unless the comparison is run on total cost rather than payment.
Illustrative arithmetic, for structure only. Consider a piece of equipment quoted at 100,000 in local currency. Structure A offers a promotional rate with no discount on the equipment. Structure B offers a discount on the equipment at a standard market rate. The operator compares monthly payments, finds them within a small margin of each other, and treats the two as equivalent. Running instead the total of all payments plus any end-of-term amount, across the full term, may show a difference of several thousand in either direction. The point of the exercise is not the number, which will vary entirely by file. The point is that the comparison is only meaningful when run on total cost, and that a payment comparison cannot surface it. These figures are illustrative and are not a quote, a rate, or a prediction.
The Capital Structure Tool compares cash, loan, lease, and hybrid structures across each cost category on a total-cost basis rather than a payment basis. For a full view of how equipment paper sits alongside the other financing a clinic uses, the financing programs reference maps every structure side by side for both the Canadian and US markets.
What separating the two prices looks like in practice
The correction is not adversarial and does not require becoming a difficult customer. It requires asking two questions instead of one.
Ask what the equipment costs, independent of financing. Establishing the purchase price as a standalone number before financing is discussed means any subsequent financing conversation is measured against a fixed reference point rather than a moving one.
Obtain one outside quote. A single competing quote from an independent equipment finance provider or the clinic's own bank converts an unverifiable offer into a comparison. Sometimes it confirms the vendor program is the better structure, which is a useful thing to know with certainty rather than by assumption. Sometimes it does not.
There is a secondary effect worth noting. An operator who arrives with financing already arranged is negotiating as a cash-equivalent buyer, and the equipment discussion proceeds on the equipment alone. That is a different conversation from one where the seller is supplying both the asset and the means of paying for it.
None of this argues against vendor financing. Manufacturer programs are frequently competitive, occasionally the best available structure, and consistently the fastest to execute. Speed has real value when equipment is needed on a deadline. The argument is only that an operator should know which of those situations they are in, rather than assume it.
How this varies by practice type
The weight of this decision tracks how large the equipment line is within a clinic's total project, and that varies substantially across specialties.
For dental general practice, dental specialties, and orthodontics, equipment is the dominant capital line. Operatories, digital radiography, and cone beam imaging are typically purchased through a small number of manufacturer and distributor relationships, and those relationships routinely include finance programs. This is where the two-price dynamic carries the most dollars.
For med spa, aesthetic medicine, and dermatologic practices, energy-based device platforms are both the largest capital item and the most actively marketed. Manufacturer finance programs are close to standard in this segment. The faster technology cycle also makes end-of-term structure unusually important, because the practical question is not only what the platform costs but what position the clinic is in when the next generation of the device arrives.
For optometry, the diagnostic suite and dispensary equipment both finance conventionally, and both are commonly quoted with financing attached.
For audiology and podiatry, the anchor assets are meaningful but fewer. A sound booth or a radiography unit is a single significant decision rather than a recurring one, which means the operator has less accumulated experience to draw on and correspondingly more reason to obtain an outside comparison.
For physiotherapy, chiropractic, rehabilitation and allied health, IV therapy, and general medical practice, equipment is real but rarely the binding constraint. In these specialties the fit-out and the working capital required to fund the ramp usually exceed the equipment line, and financing attention is better spent there.
For mental health practice, equipment financing is largely beside the point. The financing questions in that specialty are working capital questions.
The tax layer, which is country-specific
Structure choice carries a tax consequence, and the pattern differs between markets.
In Canada, payments under an operating lease are generally deducted as an operating expense as incurred, while purchased equipment is capitalized and written off over time through capital cost allowance, with the schedule depending on the asset's class.
In the United States, payments under a true lease are generally deducted as incurred, while purchased equipment is capitalized and depreciated and may qualify for accelerated treatment within the limits in effect for the tax year.
In both markets, whether an agreement is characterized as a lease or as a conditional sale determines which treatment applies, and that characterization depends on the terms of the specific agreement rather than on what the document is titled. This is a question for the clinic's accountant before signing, not after. An arrangement that appears advantageous on rate can be less so once the tax character is settled, and the reverse is equally true.
The short version
Vendor financing exists because it works for the manufacturer. That is not a criticism. It is a description, and it is the reason the arrangement is available at the moment of purchase in the first place.
The operator's task is narrow. Establish what the equipment costs on its own. Obtain one outside quote. Compare on total cost across the full term rather than on the monthly payment. Confirm the tax treatment with an accountant before signing rather than after.
Four steps, and they can be completed inside a week. What they produce is not necessarily a better deal, because sometimes the vendor program was already the better deal. What they produce is knowing.
- Clinic Equipment Financing: Lease vs. Buy
- What Equipment Lenders Approve for a Clinic
- How Equipment Financing Rates Are Determined
- Equipment Refresh: Replacing Versus Keeping